معرفی
Patrick G. O'Connor is the Dan Adams and Amanda Adams Professor of General Medicine and Chief of the Section of General Internal Medicine at Yale School of Medicine. He holds appointments in the Department of Internal Medicine and co-leads initiatives in Addiction Medicine. His primary research focuses on integrating addiction treatment strategies into primary care settings, particularly addressing opioid dependence and alcohol use disorders. He has pioneered studies on opioid withdrawal management, buprenorphine therapy, and naltrexone use in primary care. Dr. O'Connor is also a leader in medical education, serving as past president of the American Board of Addiction Medicine and the Association for Multidisciplinary Education and Research on Substance use and Addiction (AMERSA).
Educational Background
- Bachelor of Science in Biology, Union College (1978)
- Doctor of Medicine, Albany Medical College (1982)
- Master of Public Health, Yale University School of Medicine (1988)
Research Interests
Dr. O'Connor's work emphasizes bridging addiction medicine with primary care. Key areas include:
- Optimizing emergency department interventions for opioid use disorder (e.g., buprenorphine initiation)
- Evaluating primary care-based treatments for alcohol dependence
- Implementing evidence-based practices in diverse healthcare settings
- Reducing disparities in addiction treatment access
Awards & Recognition
Recipient of prestigious awards including the David C. Lewis Award (2024), Robert J. Glaser Award (2019), and John P. McGovern Award (2017). Recognized for leadership in addiction medicine education and clinical innovation.
Professional Activities
Serves on editorial boards of JAMA, Annals of Internal Medicine, and Substance Abuse. Leads initiatives in health equity, including studies on payor mix segregation in primary care clinics.